Literature DB >> 35739237

A SNIPpet of safety: a Goldilocks approach in CAR-T therapy.

Mehdi Benzaoui1,2, Naomi Taylor3,4, Nirali N Shah5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35739237      PMCID： PMC9253012          DOI： 10.1038/s41422-022-00682-2

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   46.297


× No keyword cloud information.
  6 in total

1.  Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.

Authors:  Shivani Srivastava; Alexander I Salter; Denny Liggitt; Sushma Yechan-Gunja; Megha Sarvothama; Kirsten Cooper; Kimberly S Smythe; Jarrod A Dudakov; Robert H Pierce; Christoph Rader; Stanley R Riddell
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

2.  Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia.

Authors:  Michael A Pulsipher; Xia Han; Shannon L Maude; Theodore W Laetsch; Muna Qayed; Susana Rives; Michael W Boyer; Hidefumi Hiramatsu; Gregory A Yanik; Tim Driscoll; G Doug Myers; Peter Bader; Andre Baruchel; Jochen Buechner; Heather E Stefanski; Creton Kalfoglou; Kevin Nguyen; Edward R Waldron; Karen Thudium Mueller; Harald J Maier; Gabor Kari; Stephan A Grupp
Journal:  Blood Cancer Discov       Date:  2021-12-01

3.  Enhanced safety and efficacy of protease-regulated CAR-T cell receptors.

Authors:  Louai Labanieh; Robbie G Majzner; Dorota Klysz; Elena Sotillo; Chris J Fisher; José G Vilches-Moure; Kaithlen Zen B Pacheco; Meena Malipatlolla; Peng Xu; Jessica H Hui; Tara Murty; Johanna Theruvath; Nishant Mehta; Sean A Yamada-Hunter; Evan W Weber; Sabine Heitzeneder; Kevin R Parker; Ansuman T Satpathy; Howard Y Chang; Michael Z Lin; Jennifer R Cochran; Crystal L Mackall
Journal:  Cell       Date:  2022-04-27       Impact factor: 66.850

4.  Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia.

Authors:  Simon F Lacey; Elena J Orlando; Joseph A Fraietta; Iulian Pruteanu-Malinici; Mercy Gohil; Stefan Lundh; Alina C Boesteanu; Yan Wang; Roddy S O'Connor; Wei-Ting Hwang; Edward Pequignot; David E Ambrose; Changfeng Zhang; Nicholas Wilcox; Felipe Bedoya; Corin Dorfmeier; Fang Chen; Lifeng Tian; Harit Parakandi; Minnal Gupta; Regina M Young; F Brad Johnson; Irina Kulikovskaya; Li Liu; Jun Xu; Sadik H Kassim; Megan M Davis; Bruce L Levine; Noelle V Frey; Donald L Siegel; Alexander C Huang; E John Wherry; Hans Bitter; Jennifer L Brogdon; David L Porter; Carl H June; J Joseph Melenhorst
Journal:  Nat Med       Date:  2018-04-30       Impact factor: 53.440

5.  4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors.

Authors:  Adrienne H Long; Waleed M Haso; Jack F Shern; Kelsey M Wanhainen; Meera Murgai; Maria Ingaramo; Jillian P Smith; Alec J Walker; M Eric Kohler; Vikas R Venkateshwara; Rosandra N Kaplan; George H Patterson; Terry J Fry; Rimas J Orentas; Crystal L Mackall
Journal:  Nat Med       Date:  2015-05-04       Impact factor: 53.440

6.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events.

Authors:  Marcela V Maus; Sara Alexander; Michael R Bishop; Jennifer N Brudno; Colleen Callahan; Marco L Davila; Claudia Diamonte; Jorg Dietrich; Julie C Fitzgerald; Matthew J Frigault; Terry J Fry; Jennifer L Holter-Chakrabarty; Krishna V Komanduri; Daniel W Lee; Frederick L Locke; Shannon L Maude; Philip L McCarthy; Elena Mead; Sattva S Neelapu; Tomas G Neilan; Bianca D Santomasso; Elizabeth J Shpall; David T Teachey; Cameron J Turtle; Tom Whitehead; Stephan A Grupp
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.